Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease

Published:2018-03-21 Issue:11 Volume:24 Page:1239-1249
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Fujimori Naoyuki,Umemura Takeji,Kimura Takefumi,Tanaka Naoki,Sugiura Ayumi,Yamazaki Tomoo,Joshita Satoru,Komatsu Michiharu,Usami Yoko,Sano Kenji,Igarashi Koji,Matsumoto Akihiro,Tanaka Eiji

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference47 articles.

1. Targeting nuclear receptors for the treatment of fatty liver disease

2. The epidemiology of non-alcoholic fatty liver disease

3. Human Fatty Liver Disease: Old Questions and New Insights

4. Kobyliak N, Abenavoli L. The role of liver biopsy to assess non-alcoholic fatty liver disease. Rev Recent Clin Trials 2014; 9: 159-169

5. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unearthing the Potential Therapeutic Effects of Oxyresveratrol Based on Intrinsic Links between Pharmacological Effects: Implications for the Gut–Liver–Brain Axis;Pharmaceuticals;2024-08-13

2. Sodium/bile acid co-transporter inhibitors currently in preclinical or early clinical development for the treatment of primary biliary cholangitis;Expert Opinion on Investigational Drugs;2024-04-24

3. Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease;Communications Medicine;2024-04-16

4. Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs;Hepatology Research;2024-03-27

5. Inhibition of autotaxin alleviates pathological features of hepatic encephalopathy at the level of gut–liver–brain axis: an experimental and bioinformatic study;Cell Death & Disease;2023-08-01